Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
NCT01276106 is registered in ClinicalTrials.gov with TWi Biotechnology, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase II Study of AC-201 in Patients With Type 2 Diabetes Mellitus
- Lead sponsor
- TWi Biotechnology, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2011
- Completion date
- March 31, 2012
- Enrollment
- 259 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes mellitus